» Articles » PMID: 383614

Opsonization of Cryptococcus Neoformans by Human Immunoglobulin G: Role of Immunoglobulin G in Phagocytosis by Macrophages

Overview
Journal Infect Immun
Date 1979 Jul 1
PMID 383614
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The role of immunoglobulin G (IgG) as an opsonin in phagocytosis of Cryptococcus neoformans by macrophages was investigated. Labeling with 125I showed that IgG isolated from normal human serum bound to non-encapsulated C. neoformans. Furthermore, IgG-opsonized cryptococci were agglutinated by anti-serum to IgG heavy chains, indicating that normal human serum contains antibody that will bind to the yeast surface. The IgG isolated from normal serum accounted for all opsonizing activity found in normal human serum, since differences were not noted between the opsonizing activities of whole serum, heat-inactivated serum and purified IgG when these opsonins were compared at equivalent concentrations of IgG. Phagocytosis of IgG-opsonized cryptococci was inhibited by anti-macrophage IgG, a reagent known to block Fc-mediated attachment and ingestion, and by pepsin digestion of opsonizing IgG. Thus, IgG opsonization is an Fc-dependent process. Opsonizing IgG appears to play its major role during the attachment phase of phagocytosis, since antimacrophage IgG blocked attachment of cryptococci to macrophages but could not block ingestion of IgG-opsonized cryptococci that had been allowed to attach to macrophages. Ingestion of opsonized cryptococci was not blocked by 2-deoxy-D-glucose, a reagent known to block Fc-mediated ingestion, thus confirming that IgG has a primary role in attachment and suggesting that ingestion is mediated by a process that is not Fc dependent.

Citing Articles

Deciphering neutrophil dynamics: Enhanced phagocytosis of elastic particles and impact on vascular-targeted carrier performance.

Lee J, Guevara M, Akanbi O, Hoff J, Kupor D, Brannon E Sci Adv. 2025; 11(1):eadp1461.

PMID: 39752488 PMC: 11698085. DOI: 10.1126/sciadv.adp1461.


Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.

Aslanyan L, Lee H, Ekhar V, Ramos R, Martinez L Infect Immun. 2018; 87(2).

PMID: 30510106 PMC: 6346126. DOI: 10.1128/IAI.00113-18.


Antibody therapy for histoplasmosis.

Nosanchuk J, Zancope-Oliveira R, Hamilton A, Guimaraes A Front Microbiol. 2012; 3:21.

PMID: 22347215 PMC: 3270318. DOI: 10.3389/fmicb.2012.00021.


Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functions.

Guimaraes A, Frases S, Pontes B, de Cerqueira M, Rodrigues M, Viana N Infect Immun. 2010; 79(2):918-27.

PMID: 21134968 PMC: 3028823. DOI: 10.1128/IAI.00673-10.


Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum.

Steenbergen J, Nosanchuk J, Malliaris S, Casadevall A Infect Immun. 2003; 71(9):4862-72.

PMID: 12933827 PMC: 187309. DOI: 10.1128/IAI.71.9.4862-4872.2003.


References
1.
Kozel T . Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun. 1977; 16(1):99-106. PMC: 421494. DOI: 10.1128/iai.16.1.99-106.1977. View

2.
SWENSON F, Kozel T . Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages. Infect Immun. 1978; 21(3):714-20. PMC: 422057. DOI: 10.1128/iai.21.3.714-720.1978. View

3.
Kaplan G . Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand J Immunol. 1977; 6(8):797-807. DOI: 10.1111/j.1365-3083.1977.tb02153.x. View

4.
WEIR D, Ogmundsdottir H . Non-specific recognition mechanisms by mononuclear phagocytes. Clin Exp Immunol. 1977; 30(2):323-9. PMC: 1541108. View

5.
Czop J, Fearon D, Austen K . Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes. J Immunol. 1978; 120(4):1132-8. View